iBio Inc (AMEX:IBIO)
$ 1.92 -0.062 (-3.13%) Market Cap: 16.56 Mil Enterprise Value: 28.59 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 36/100

Ibio Inc at JMP Securities Life Sciences Conference Transcript

May 16, 2023 / 04:00PM GMT
Release Date Price: $18.6 (-1.24%)
Roy Buchanan
JMP Securities - Moderator

Thank you everybody joining us again at the JMP Securities Life Sciences Conference. My name is Roy Buchanan, one of the biotech equity analysts. Our next company we're happy to have is iBio. And we have Martin Brenner, who's the Chief Scientific Officer and Interim Chief Executive Officer. So, thank you for joining us, Martin.

Martin Brenner
iBio, Inc. - Interim CEO & CSO

Thanks for having us. Really good to see you in person for the first time.

Questions & Answers

Roy Buchanan
JMP Securities - Moderator

Yes, good to see you too. So maybe the company has undergone quite a transformation recently, still undergoing a transformation, just maybe lay out for us how the company is structured today? How many people do you have in R&D? I'm following the acquisition of RubrYc, especially directed at the discovery platform? And what are your core areas of investigation today?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot